As of this writing, he did not hold a position in any of the aforementioned securities. Article printed from InvestorPlace Media, http://investorplace.com/2013/03/biotech-movers-acadia-jumps-affymax-crashes/.
Cyprus may serve as a grave reminder of the global economy’s tenuous grip on stability, but U.S. investors have shown a willingness to overlook it as a blip, a passing tremor that the media and some pundits are blowing way out of proportion. …
Sees FY08 EPS of $0.52-$0.58, versus the consensus of $0.47. Obagi Medical Products (Nasdaq: OMPI) 14.8% …
The Australian national, who has been at the helm of WIPO since 2008, noted that the event would enable global stakeholders to take stock of what has been achieved and review plans going forward. He welcomed the implementation …
In April this year Finland went to the polls -- and the right wing populist party, the True Finns, gained almost 20 per cent of the vote. This upset almost 30 years of consensus politics, and shows an upsurge in anti-European Union, anti …
Details of the proposed solution were not available at the time of publication. Department of Energy deputy director-general Ompi Aphane said a solution had been found and the department was awaiting confirmation from Eskom. Eskom …
“World stock indexes have struggled to continue the rally that began in 2009. Investors have begun to question the validity of the rally. However, there are small pockets of strength McCall continues to say, “With approximately 160 biotech …
OMP is looking to trade as "OMPI" on the Nasdaq. Listed as a day-to-day possibility is biotech company Xenogen, which has been on deck since mid-January. "If they don't make it this week they will probably be pulled off the calendar …
We’ll see if any real solid news comes out confirming or denying the talk out there. Until then, it’s just another stock moving on rumors.